1-acetyl-1-methyl-2-nitroso-2-phenylhydrazine has been researched along with Glioblastoma in 1 studies
*Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, K; Gu, X; Huang, C; Li, Y; Liu, G; Mao, J; Nie, M; Qi, C; Sun, M; Wen, R; Zhang, K; Zhang, W; Zhang, X; Zhang, Z | 1 |
1 other study(ies) available for 1-acetyl-1-methyl-2-nitroso-2-phenylhydrazine and Glioblastoma
| Article | Year |
|---|---|
Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy.
Topics: B7-H1 Antigen; Biomimetics; Cell Line, Tumor; Glioblastoma; Humans; Immunotherapy; Melanins; Nanoparticles; Phototherapy | 2023 |